Article info
Clinical science
Valuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation method
- Correspondence to Professor Katherine Payne, Manchester Centre for Health Economics, Institute of Population Health, University of Manchester, Jean McFarlane Building, Oxford Road, Manchester M13 9PL, UK; katherine.payne{at}manchester.ac.uk
Citation
Valuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation method
Publication history
- Received December 21, 2012
- Revised March 5, 2013
- Accepted May 7, 2013
- First published June 6, 2013.
Online issue publication
August 25, 2016
Article Versions
- Previous version (25 August 2016).
- Previous version (25 August 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions